Polymeric nanoparticle-based mRNA vaccine is protective against influenza virus infection in ferrets
New therapies and vaccines based on nucleic acids combined with an efficient nanoparticle delivery vehicle have a broad applicability for different disease indications. An alternative delivery technology for the successfully applied lipid nanoparticles in mRNA SARS-CoV-2 vaccines are nanoparticles c...
Saved in:
Main Authors: | Gijs Hardenberg (Author), Chantal Brouwer (Author), Rachelle van Gemerden (Author), Nicola J. Jones (Author), Anthony C. Marriott (Author), Jaap Rip (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polymeric Nanoparticles Enable mRNA Transfection and Its Translation in Intervertebral Disc and Human Joint Cells, Except for M1 Macrophages
by: Katrin Agnes Muenzebrock, et al.
Published: (2024) -
Polymeric Nanoparticles for Drug Delivery in Osteoarthritis
by: Adriano P. Pontes, et al.
Published: (2022) -
Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles
by: Christophe Delehedde, et al.
Published: (2021) -
The ferret as a model organism to study influenza A virus infection
by: Jessica A. Belser, et al.
Published: (2011) -
Recent Advances in Lipid Nanoparticles for Delivery of mRNA
by: Lei Yang, et al.
Published: (2022)